Voxel level survival analysis of grey matter volume and incident mild cognitive impairment or Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 46, Issue 1, 2015, Pages 167-178

  Zeifman, Lubov E ^a   Eddy, William F ^a,b   Lopez, Oscar L ^c   Kuller, Lewis H ^d   Raji, Cyrus ^e   Thompson, Paul M ^f,g   Becker, James T ^c  

^a CARNEGIE MELLON UNIVERSITY   (United States)

^b Carnegie Mellon University   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Cox survival model; incidence; mild cognitive impairment; MRI

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; BRAIN SIZE; COGNITION; CONTROLLED STUDY; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MESIAL TEMPORAL LOBE; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR CINGULATE; PRECUNEUS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROBABILITY; SURVIVAL; TEMPORAL LOBE; VOXEL BASED MORPHOMETRY; CHI SQUARE DISTRIBUTION; COGNITIVE DYSFUNCTION; DISEASE COURSE; INCIDENCE; MORTALITY; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PSYCHOLOGICAL RATING SCALE; SURVIVAL ANALYSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CHI-SQUARE DISTRIBUTION; COGNITIVE DYSFUNCTION; DISEASE PROGRESSION; FEMALE; GRAY MATTER; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; SURVIVAL ANALYSIS;

EID: 84929312098     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150047     Document Type: Article

References (77)

1. Jack CR, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Waring SC, Tangalos EG, Kokmen E (1999) Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52, 1397-1403.
2. Lopez OL, Becker JT, Chang YF, Sweet RA, Dekosky ST, Gach MH, Carmichael OT, McDade E, Kuller LH (2012) Incidence of mild cognitive impairment in the Pittsburgh Cardiovascular Health Study-Cognition Study. Neurology 79, 1599-1606.
3. Kuller LH, Lopez OL, Newman A, Beauchamp NJ, Burke G, Dulberg C, Fitzpatrick A, Fried L, Haan MN (2003) Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology 22, 13-22.
4. Lopez OL, Klunk WE, Mathis C, Coleman RL, Price J, Becker JT, Aizenstein HJ, Snitz B, Cohen A, Ikonomovic M, McDade E, DeKosky ST, Weissfeld L, Kuller LH (2014) Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old. Neurology 83, 1804-1811.
5. Vemuri P, Weigand SD, Knopman DS, Kantarci K, Boeve BF, Petersen RC, Jack CR Jr (2011) Time-to-event voxel-based techniques to assess regional atrophy associated with MCI risk of progression to AD. Neuroimage 54, 985-991.
6. Fitzpatrick AL, Kuller LH, Ives D, Lopez OL, Jagust W, Breitner J, Jones B, Lyketsos C, Dulberg C (2004) Incidence and prevalence of dementia inthe cardiovascular health study. J Am Geriatr Soc 52, 195-204.
7. Brandt J, Spencer M, Folstein M (1988) The Telephone Interview for Cognitive Status. Neuropsychiat Neuropsychol Behav Neurol 1, 111-117.
8. Kawas C, Segal J, Stewart WF, Corrada M, Thal LJ (1994) A validation study of the dementia questionnaire. Arch Neurol 51, 901-906.
9. Jorm AF, Jacomb PA (1989) The informant questionnaire on cognitive decline in the elderly (IQCODE): Socio-demographic correlates, reliability, validity and some norms. Psychol Med 19, 1015-1022.
10. Teng EL, Chui HC (1987) The Modified Mini-Mental State (3MS) xamination. J Clin Psychiatry 48, 314-318.
11. Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson MC, Kuller LH (2003) Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognitive Study Part 1. Arch Neurology 60, 1385-1389.
12. Lopez OL, Kuller LH, Fitzpatrick A, Ives D, Becker JT, Beauchamp N (2003) Evaluations of dementia in the cardiovascular health cognition study. Neuroepidemiology 22, 1-12.
13. McKhann G, Drachman DA, Folstein MF, Katzman R, Price DL, Stadlan E (1984) Clinical diagnosis of Alzheimer's disease: Report ofthe NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939-944.
14. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Alzheimers Dement 7, 263-269.
15. American Psychiatric Association (1994) DSM-IV: Diagnostic and Statistic Manual of Mental Disorders, Fourth Edition, American Psychiatric Association, Washington, D.C.
16. WHO (1993) The ICD-10 classification of mental and behavioral disorders: diagnostic criteria for research, WHO, Geneva.
17. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R (1992) Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 42, 473-480.
18. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A (1993) Vascular dementia: Diagnostic criteria for research studies: Report of the NINDS-AIREN International Workshop. Neurology 43, 250-260.
19. McKeith IG, Dickson DW, Loew J, Emre D, B'Brien JT, Feldman H, Cummings J, Dusa JE, Lippa C, Perry EK (2005) Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology 65, 1863-1872.
20. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotempo-ral lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 51, 1546-1554.
21. Fitzpatrick A, Kuller L, Lopez OL, Kawas CH, Jagust W (2005) Survival following dementia onset: Alzheimer's disease and vascular dementia. J Neurol Sci 229-230 43-49.
22. Kawas CH, Corrada MM (2006) Alzheimer's and dementia in the oldest-old: A century of challenges. Curr Alzheimer Res 3, 411-419.
23. Bryan RN, Manolio TA, Scertz LD, Jungreis C, Poirier VC, Elster AD, Kronmal RA (1994) A method for using MR to evaluate the effectsofcardiovascular diseaseon the brain: The cardiovascular health study. AmJNeuroradiol15, 1625-1633.
24. Boyes RG, Gunter JL, Frost C, Janke AL, Yeatman T, Hill DL, Bernstein MA, Thompson PM, Weiner MW, Schuff N, Alexander GE, Killiany RJ, DeCarli C, Jack CR, Fox NC (2008) Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coils. Neuroimage 39, 1752-1762.
25. Spears JR, Greer PJ, Ziolko SK, Aizenstein HJ, Carmichael O, Becker JT, Meltzer CC (2005) Evaluation of an age-specific neurological template. Presented at the Annual Meeting of the Organization of Human Brain Mapping. Toronto Ontario, Canada; June 2005.
26. Kuller LH, Lopez OL, Jagust W, Becker JT, Fitzpatrick A, Carlson M, Breitner J, Lyketsos C, Kawas C, DeKosky ST (2004) Clinical and MRI factors for vascular dementia in the Cardiovascular Health Study Cognition study. Neurobiol Aging 25, S483.
27. Kuller LH, Shemanski L, Manolio T, Haan M, Fried L, Bryan N, Burke GL, Tracy R, Bhadelia R (1998) Relationship between Apo E, MRI findings, and cognitive function in the cardiovascular health study. Stroke 29, 388-398.
28. Manolio TA, Kronmal RA, Burke GL, Poirier V, O'Leary DH, Garden JM, Fried LP, Steinberg EP, Bryan RN (1994) Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. Stroke 25, 318-327.
29. Manolio TA, Burke GL, O'Leary DH, Evans G, Beauchamp N, Knepper L, Ward B (1999) Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults : The Cardiovascular Health Study. CHS Collaborative Research Group. Arterioscler Thromb Vasc Biol 19, 356-365.
30. Longstreth WT, Arnold AM, Manolio T, Burke G, Bryan N, Jungreis CA, O'Laery D (2000) Clinical correlates of ventricular and sulcal size on cranial magnetic resonance imaging of 3301 elderly people. The cardiovascular health study. Neu-roepidemiology 19, 30-42.
31. Longstreth WT, Arnold AM, Beauchamp NJ, Manolino TA, Lefkowitz D, Jungreis C, Hirsch CH, O'Leary DH, Furberg CD (2005) Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: The Cardiovascular Health Study. Stroke 36, 56-61.
32. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler M (2003) Silent brain infarcts and white matter lesions increase stroke risk in the general population: The Rotterdam scan study. Stroke 34, 1126-1129.
33. van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM (2008) Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke 39, 2712-2719.
34. Mogi M, Horiuchi M (2011) Clinical interaction between brain and kidney in small vessel disease. Cardiol Res Prac 2011, 306189.
35. Swan GE, DeCarli C, Miller BL, Reed T, Wolf PA, Jack LM, Carmelli D (1998) Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology 51, 986-993.
36. de Leeuw F-E, dr Groot JC, Oudkerk M, Witterman JCM, Hofman A, van Gjin J, Breteler MMB (2002) Hypertension andcerebral white matterlesionsinaprospective cohort study. Brain 125, 765-772.
37. Dufouil C, de Kersaint-Gilly A, Besancon V, Levy C, Auffray E, Brunnereau L, Alperovitch A, Tzourio C (2001) Longitudinal study of blood pressure and white matter hyperintensities. The EVA MRI Cohort. Neurology 56, 921-926.
38. Grambsch P, Therneau T (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81, 515-526.
39. Wechsler D (1981) Wechsler Adult Intelligence Scale-Revised, The Psychological Corporation, New York.
40. Grafton ST, Sumi SM, Stimac GK, Alvord EC, Shaw C, Nochlin D (1991) Comparison of postmortem magnetic resonance imaging and neuropsthologic findings in the cerebral white matter. Arch Neurol 48, 293-298.
41. Kobari M, Meyer JS, Ichijo M (1990) Leuko-Araiosis, cerebral atrophy, and cerberal perfusion in normal aging. Arch Neurol 47, 161-165.
42. Scheltens P, Barkhof F, Leys D, Wolters E, Ravid R, Kamphorst W (1995) Histopathologiccorrelatesofwhite matter changes on MRI in Alzheimer's disease. Neurology 45, 883-888.
43. Hall AM, Moore RY, Lopez OL, Kuller LH, Becker JT (2008) Basal forebrain atrophy is a presymptomatic marker for Alzheimer's disease. Alzheimers Dement 4, 271-279.
44. Johnson VE (2013) Revised standards for statistical evidence. Proc Natl Acad Sci U S A 110, 19313-19317.
45. Elias MF, Beiser A, Wolf PA, Au R, White RF, RB, DA (2000) The preclinical phase of Alzheimer disease. A 22-year prospective study of the Framingham cohort. Arch Neurol 57, 808-813.
46. Killiany RJ, Gomez-Isla T, Moss M, Kikinis R, Sandor T, Jolesz F, Tanzi R, Jones K, Hyman BT, Albert MS (2000) Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol 47, 430-439.
47. Schott JM, Fox NC, Frost C, Scahill RI, Janssen JC, Chan D, Jenkins R, Rossor MN (2003) Assessing the onsetofstructural changes in familial Alzheimer's disease. Ann Neurol 53, 181-188.
48. Galvin JE, Pawlishta KK, Wilkins K, McKeel DW, Xiong G, Grant E, Storandt M, Morris JC (2005) Predictors of pre-clinical Alzheimer disease and dementia. A clinicopathologic study. Arch Neurol 62, 758-765.
49. Tierney MC, Yao C, Kiss A, McDowell I (2005) Neuropsy-chological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology 64, 1853-1859.
50. Desai AK, Grossberg GT (2005) Diagnosis and treatment of Alzheimer's disease. Neurology 64, S34-S39.
51. Morris JC, Cummings J (2005) Mild cognitive impairment (MCI) represents early-stage Alzheimer's disease. J Alzheimers Dis 7, 235-239.
52. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg L (2001) Mild cognitive impairment represents early-stageAlzheimerdisease.Arch Neurol58, 397-405.
53. Jack CR, Petersen RC, Xu YC, Waring SC, O'Brien PC, Tangalos EG, Smith GE, Ivnik RJ, Kokmen E (1997) Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 49, 786-794.
54. Jack CR, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Waring SC, Tangalos EG, Kokmen E (1999) Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52, 1397-1403.
55. Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, Sheline YI, Klunk WE, Mathis CA, Morris JC, Mintun MA (2005) Molecular, structural, and functional characterization of Alzheimer's disease: Evidence for a relationship between default activity, amyloid, and memory. J Neurosci 25, 7709-7717.
56. Chetelat G, Baron JC (2003) Early diagnosis of Alzheimer's disease: Contribution of structural neuroimaging. Neuroimage 18, 525-541.
57. Rusinek H, Endo Y, De Santi S, Frid D, Tsui WH, Segal S, Convit A, de Leon MJ (2004) Atrophy rate in medial temporal lobe during progression of Alzheimer disease. Neurology 63, 2354-2359.
58. Berent S, Giordani B, Foster N, Minoshima S, Lajiness-O'Neil R, Koeppe R, Kuhl DE (1999) Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease. J Psychiatr Res 33, 7-16.
59. De Santi S, de Leon MJ, Rusinek H, Convit A, Tarshish CY, Roche A, Tsui WH, Kandil E, Boppana M, Daisley K, Wang GJ, Schlyer D, Fowler J (2001) Hippocampal formation, glucose metabolism, and volume losses in MCI and AD. Neurobiol Aging 22, 529-539.
60. Jagust WJ, Eberling JL, Wu CC, Finkbeiner A, Mungas D, Haan MN (2002) Brainfunction and cognitioninacommunity sample of elderly Latinos. Neurology 59, 378-383.
61. Chetelat G, Desgranges B, de la Sayette V, Viader F, Eustache F, Baron J-C (2003) Mild cognitive impairment. Can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology 60, 1374-1377.
62. de Leon MJ, Golomb J, George AE, Convit A, Tarshish CY, McRae T, DeSanti S, Smith G, Ferris SH, Noz M, Rusinek H (1993) The radiologic prediction of Alzheimer disease: The atrophic hippocampal formation. AJNR 14, 897-906.
63. Soininen HS, Partanen K, Pitkanen A, Vainio P, Hanninen T, Hallikanen M, Koivisto K, Reikkinen PJ (1994) Volumetric MRI analysis of the amygdala and the hippocampua in subjects with age-associated memory impairment: Correlation to visual and verbal memory. Neurology 44, 1660-1668.
64. Du AT, Schuff N, Amend D, Laakso MP, Hsu YY, Jagust WJ, Yaffe K, Framer JH, Reed B, Norman D, Chui HC, Weiner MW (2001) Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry 71, 441-447.
65. Visser PJ, Scheltens P, Verhey FRJ, Schmand B, Launer LJ, Jolles J, Jonker C (1999) Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol 246, 477-485.
66. Becker JT, Davis SA, Hayaski KM, Meltzer CC, Thompson PM, Lopez OL, Toga AW (2006) Three-dimensional patterns of hippocampal atrophy in mild cognitive impairment. Arch Neurol 63, 97-101.
67. Rosano R, Aizenstein HJ, Wu M, Newman A, Becker JT, Lopez OL, Kuller LH (2007) Focal atrophy and cerebrovascu-lar disease increase dementia risk among cognitively normal older adults. J Neuroimaging 17, 148-155.
68. den Heijer T, Geerlings MJ, Hoebeek FE, Hofman A, Koudstaal PJ, Bereteler MB (2006) Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people. Arch Gen Psychiatry 63, 57-62.
69. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D (1996) Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 334, 752-758.
70. Carlson NE, Moore MM, Dame A, Howieson D, Silbert LC, Quinn JF, Kaye JA (2008) Trajectories of brain loss in aging and the development of cognitive impairment. Neurology 70, 828-833.
71. Carmichael OT, Kuller LH, Lopez OL, Thompson PM, Dutton RA, Lu A, Lee SE, Lee JY, Aizenstein HJ, Meltzer CC, Liu Y, Toga AW, Becker JT (2007) Acceleration of cerebral ventricular expansion in the Cardiovascular Health Study. Neurbiol Aging 28, 1316-1321.
72. Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Pankratz VS, Donohue MC, Trojanowski JQ (2013) Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomark-ers. Lancet Neurol 12, 207-216.
73. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9, 119-128.
74. Knopman DS, Jack CR Jr, Wiste HJ, Weigand SD, Vemuri P, Lowe V, Kantarci K, Gunter JL, Senjem ML, Ivnik RJ, Roberts RO, Boeve BF, Petersen RC (2012) Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease. Neurology 78, 1576-1582.
75. Zamrini E, Maestu F, Pekkonen E, Funke M, Makela J, Riley M, Bajo R, Sudre G, Fernandez A, Castellanos N, Del Pozo F, Stam CJ, van Dijk BW, Bagic A, Becker JT (2011) Magne-toencephalography as a putative biomarker for Alzheimer's disease. Int J Alzheimers Dis 2011, 280289.
76. Andresen EM, Malmgren JA, Carter WB, Patrick DL (1994) Screening for depression in well older adults: Evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med 10, 77-84.
77. Holmes CJ, Hoge R, Collins L, Woods R, Toga AW, Evans AC (1998) Enhancement of MR images using registration for signal averaging. J Comput Assist Tomogr 22, 324-333.